Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Viemed Healthcare (VMD) EBITDA Margin (2018 - 2026)

Viemed Healthcare filings provide 8 years of EBITDA Margin readings, the most recent being 10.99% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 36.0% to 10.99% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.49%, a 78.0% increase, with the full-year FY2025 number at 8.49%, up 347.0% from a year prior.
  • EBITDA Margin hit 10.99% in Q4 2025 for Viemed Healthcare, up from 7.85% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 12.95% in Q4 2021 to a low of 3.08% in Q2 2022.
  • Median EBITDA Margin over the past 5 years was 6.32% (2021), compared with a mean of 6.76%.
  • Biggest five-year swings in EBITDA Margin: crashed -3953bps in 2021 and later soared 379bps in 2024.
  • Viemed Healthcare's EBITDA Margin stood at 12.95% in 2021, then plummeted by -51bps to 6.35% in 2022, then increased by 8bps to 6.85% in 2023, then skyrocketed by 55bps to 10.63% in 2024, then grew by 3bps to 10.99% in 2025.
  • The last three reported values for EBITDA Margin were 10.99% (Q4 2025), 7.85% (Q3 2025), and 8.08% (Q2 2025) per Business Quant data.